Aspira Pathlab & Diagnostics Limited (BOM:540788)
India
· Delayed Price · Currency is INR 53.50
0.00 (0.00%)
At close: Jul 11, 2025
BOM:540788 Revenue
In the fiscal year ending March 31, 2025, Aspira Pathlab & Diagnostics had annual revenue of 219.99M INR with 66.60% growth. Aspira Pathlab & Diagnostics had revenue of 57.77M in the quarter ending March 31, 2025, with 51.31% growth.
Revenue
219.99M
Revenue Growth
+71.94%
P/S Ratio
2.50
Revenue / Employee
n/a
Employees
115
Market Cap
550.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 219.99M | 87.94M | 66.60% |
| Mar 31, 2024 | 132.05M | -12.52M | -8.66% |
| Mar 31, 2023 | 144.57M | -50.85M | -26.02% |
| Mar 31, 2022 | 195.42M | 43.37M | 28.52% |
| Mar 31, 2021 | 152.05M | 67.89M | 80.66% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,561.48B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |